Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Brian L. Pettiford"'
Publikováno v:
Cureus
Thymomas are relatively uncommon malignancies of the anterior mediastinum and present with four distinct histological types based on the specific epithelial to lymphocyte ratio: spindle cell, epithelial predominant, lymphocyte predominant, or mixed.
Autor:
James D. Luketich, Ghulam Abbas, Brian L. Pettiford, Matthew J. Schuchert, Rodney J. Landreneau
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 140:1168-1173
Objectives Mechanical stapling devices have been established as the mainstay of therapy in the selective isolation and division of bronchial and vascular structures during anatomic lung resection. Few data are available regarding the application of e
Autor:
James D. Luketich, David O. Wilson, Arman Kilic, James R. Landreneau, Robert Jack, Brian L. Pettiford, Rodney J. Landreneau, Ghulam Abbas, Matthew J. Schuchert, Joshua P. Landreneau, Arjun Pennathur, Sebastien Gilbert
Publikováno v:
Annals of Surgical Oncology. 17:123-128
Central lung cancers with pulmonary hilar involvement can pose a technical challenge when a lateral thoracotomy is used. Proximal vascular control and pulmonary vascular dissection from this approach can be challenging and potentially dangerous. We d
Autor:
Rodney J. Landreneau, Matthew J. Schuchert, James D. Luketich, Arjun Pennathur, Joshua P. Landreneau, James R. Landreneau, Brian L. Pettiford, Ghulam Abbas
Publikováno v:
Surgery. 146:749-756
Background Esophageal perforation is an important therapeutic challenge. We hypothesized that patients with minimal mediastinal contamination at the time of diagnosis could be managed successfully with nonoperative treatment modalities. Methods We pe
Autor:
Ricardo J. Parker, Brian L. Pettiford, James D. Luketich, Thomas A. d’Amato, William A. Ricketts, Rodney J. Landreneau, Mathew J. Schuchert
Publikováno v:
Annals of Surgical Oncology. 16:2848-2855
Recent adjuvant chemotherapy trials after resection of stage II and III non-small cell lung cancer (NSCLC) have identified important survival differences among patients with immunohistochemical evidence suggesting platinum resistance. No clinical inf
Autor:
Arjun Pennathur, Matthew J. Schuchert, Rodney J. Landreneau, James R. Landreneau, Brian L. Pettiford, Joshua P. Landreneau, Arman Kilic, James D. Luketich
Publikováno v:
The Annals of Thoracic Surgery. 87:1662-1668
Background Anatomic segmentectomy for stage I non-small cell lung cancer (NSCLC) offers the potential of surgical cure with preservation of lung function. This may be of particular importance in elderly NSCLC patients with declining cardiopulmonary s
Autor:
Ricardo S. Santos, Amgad El-Sherif, Rodney J. Landreneau, John M. Close, Hiran C. Fernando, James D. Luketich, Brian L. Pettiford
Publikováno v:
Annals of Surgical Oncology. 14:2400-2405
Local recurrence is a major concern after sublobar resection (SR) of non-small cell lung cancer (NSCLC). We postulate that a large proportion of local recurrence is related to inadequate resection margins. This report analyzes local recurrence after
Publikováno v:
Thoracic Surgery Clinics. 17:175-190
Segmentectomy demands a thorough knowledge of the three-dimensional bronchovascular anatomy of the lung. This anatomic detail makes segmentectomy significantly more challenging than lobectomy. Several principles must be applied when performing segmen
Publikováno v:
Thoracic Surgery Clinics. 17:25-33
Flail chest is an uncommon consequence of blunt trauma. It usually occurs in the setting of a high-speed motor vehicle crash and can carry a high morbidity and mortality. The outcome of flail chest injury is a function of associated injuries. Isolate
Autor:
Hiran C. Fernando, Ricardo S. Santos, Amgad El-Sherif, Peter F. Ferson, James D. Luketich, Susan J. Urda, Brian L. Pettiford, Rodney J. Landreneau, William E. Gooding
Publikováno v:
The Annals of Thoracic Surgery. 82:408-416
Background The appropriate use of sublobar resection versus lobectomy for stage I non–small cell lung cancer continues to be debated. A long-term analysis of the outcomes of these resections for stage I non–small cell lung cancer in a high-volume